Latest News

GeoVax Comments on Recent Vaccine Development Study Funded by the Gates Foundation
Research Article Describes Inadequate Funding Levels for Vaccines Against HIV, Malaria and Tuberculo...
Continue Reading...
GeoVax to Report Vaccine Development Progress at the 12th Vaccine Congress in Budapest
ATLANTA, GA, September 12, 2018 – GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developin...
Continue Reading...
GeoVax Strengthens Scientific Staff and Expertise
GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, today announced ...
Continue Reading...